Standard semaglutide titration: Weeks 1-4: 0.25 mg weekly Weeks 5-8: 0.5 mg weekly Weeks 9-12: 1.0 mg weekly Week 13+: 1.7 mg or 2.4 mg weekly (target dose) Hashimoto's-adjusted approach: Weeks 1-6: 0.25 mg weekly (extended to allow thyroid monitoring at week 6) Weeks 7-12: 0.5 mg weekly (TSH check before increasing) Weeks 13-16: 1.0 mg weekly Week 17+: Assess whether higher doses are needed The extended timeline allows for thyroid function checks at each step, ensuring levothyroxine doses are adjusted proactively rather than reactively
Receptor-dependent effects of melatonin in CRC: Inhibition of adenylate cyclase, reduction of cAMP levels, activation of PLC, and modulation of mitochondrial signaling through intracellular MT1 receptors are among the receptor-dependent effects of melatonin in CRC
Stacking Considerations As mentioned in the TB500 vs BPC-157 guide, stacking TB500 with: can amplify tissue recovery, enhance mobility, and reduce pain far more effectively than TB500 alone
Therefore, antioxidant therapy was acclaimed as a valuable tool to selectively kill cancer cells
Some doctors recommend its supplementation to treat cancer, as it increases the effectiveness of chemotherapy drugs and reduces their toxicity